Matthew R Patterson's Net Worth
$23.8 Million
Who is Matthew R Patterson?
Matthew R Patterson has an estimated net worth of $23.8 Million. This is based on reported shares across multiple companies, which include Vor Biopharma Inc., AMICUS THERAPEUTICS INC, 5:01 Acquisition Corp., Homology Medicines, Inc., and Audentes Therapeutics, Inc..
SEC CIK
Matthew R Patterson's CIK is 0001401018
Past Insider Trading and Trends
2018 was Matthew R Patterson's most active year for acquiring shares with 15 total transactions. Matthew R Patterson's most active month to acquire stocks was the month of January. 2008 was Matthew R Patterson's most active year for disposing of shares, totalling 100 transactions. Matthew R Patterson's most active month to dispose stocks was the month of May. 2019 saw Matthew R Patterson paying a total of $349,067.00 for 312,156 shares, this is the most they've acquired in one year. In 2020 Matthew R Patterson cashed out on 1,158,349 shares for a total of $15,687,480.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vor Biopharma Inc. (VOR) Snapshot price: $0.9001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMICUS THERAPEUTICS INC (FOLD) Snapshot price: $11.65
Acting CEO & President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +88.42% | 50K |
—
|
—
| 106.55K |
Apr 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +55.14% | 20.1K |
$0.64 | $12,822.52 | 56.55K |
Dec 2
| |||
Form 4
| -5.94% | -2.30K |
$10.00 | -$23,000.00 | 36.45K |
Scheduled
|
Oct 30 - Oct 31
| ||
Form 4
| -7.63% | -3.20K |
$10.39 | -$33,256.20 | 38.75K |
Scheduled
|
Oct 22 - Oct 23
| ||
Form 4
| -9.69% | -4.50K |
$10.62 | -$47,806.20 | 41.95K |
Scheduled
|
Oct 20 - Oct 21
| ||
Form 4
| -4.13% | -2.00K |
$13.54 | -$27,070.00 | 46.45K |
Scheduled
|
Aug 20
| ||
Form 4
| -14.17% | -8.00K |
$14.45 | -$115,631.90 | 48.45K |
Scheduled
|
Aug 18 - Aug 19
| ||
Form 4/A
| -3.18% | -1.90K |
$11.01 | -$20,912.26 | 57.85K |
Scheduled
|
Jun 18 - Jun 19
| ||
Form 4/A
| -1.04% | -600.00 |
$11.44 | -$6,725.23 | 56.45K |
Scheduled
|
Jun 20
| ||
Form 4
| -2.34% | -1.40K |
$11.40 | -$15,957.23 | 58.55K |
Scheduled
|
Jun 20
| ||
Form 4
| -3.07% | -1.90K |
$11.01 | -$20,912.26 | 59.95K |
Scheduled
|
Jun 18 - Jun 19
| ||
Form 4
| -10.08% | -6.70K |
$11.16 | -$74,745.66 | 59.75K |
Scheduled
|
Jun 16 - Jun 17
| ||
Form 4
| -6.34% | -4.50K |
$10.18 | -$45,799.44 | 66.45K |
Scheduled
|
Apr 14 - Apr 16
| ||
Form 4
| -7.19% | -5.50K |
$10.48 | -$57,628.33 | 70.95K |
Scheduled
|
Apr 14
| ||
Form 4
| +18.77% | 12.08K |
$0.64 | $7,708.95 | 76.45K |
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
| +101.14% | 32.37K |
$0.64 | $20,649.51 | 64.37K |
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
5:01 Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Homology Medicines, Inc. (FIXX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Audentes Therapeutics, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -433.27K |
$60.00 | -$25,996,320.00 |
0
|
Jan 15
| |||
Form 4
| +134.66% | 150.04K |
$3.10 | $503,567.37 | 261.46K |
Dec 26 - Jan 8
| |||
Form 4
| -1.74% | -1.97K |
$59.21 | -$116,880.54 | 111.42K |
Dec 5
| |||
Form 4
|
—
|
0
|
$19.75 | -$295,733.00 | 113.39K |
Scheduled
|
Nov 8
| ||
Form 4
| -1.71% | -1.97K |
$31.02 | -$61,233.48 | 113.39K |
Sep 5
| |||
Form 4
|
—
|
0
|
$21.77 | -$490,834.70 | 115.37K |
Scheduled
|
Aug 12
| ||
Form 4
| -2.81% | -3.33K |
$37.31 | -$124,316.92 | 115.37K |
Jun 5
| |||
Form 4
|
—
|
0
|
$15.53 | -$607,980.00 | 118.7K |
Scheduled
|
Feb 25
| ||
Form 4
| +115.82% | 63.7K |
—
|
—
| 118.7K |
Feb 6
| |||
Form 4
| +266.67% | 40K |
$0.78 | $31,200.00 | 55K |
Dec 6
| |||
Form 4
|
—
|
0
|
$19.47 | -$784,992.28 | 15K |
Scheduled
|
Oct 1
| ||
Form 4
|
∞
| 15K |
$0.78 | $11,700.00 | 15K |
Sep 24
| |||
Form 4
|
—
|
0
|
$21.10 | -$489,715.12 |
0
|
Scheduled
|
Sep 18
| ||
Form 4
|
—
|
0
|
$20.17 | -$2,754,419.30 |
0
|
Scheduled
|
Jul 2 - Jul 5
| ||
Form 4
|
—
|
0
|
$19.47 | -$758,664.00 |
0
|
Scheduled
|
May 21
| ||
Form 4
|
—
|
0
|
$15.40 | -$20,463.03 |
0
|
Scheduled
|
Apr 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
| -8.03% | -15.00K |
$14.35 | -$690,269.50 | 171.81K |
Scheduled
|
Oct 2
| ||
Form 4
|
—
|
0
|
$12.92 | -$242,760.84 |
0
|
Scheduled
|
Sep 15 - Sep 18
| ||
Form 4
| -7.43% | -15.00K |
$20.00 | -$300,059.37 | 186.81K |
Scheduled
|
Jul 12 - Jul 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||